Basit öğe kaydını göster

Postpneumonic empyema in childhood

dc.contributor.authorBelet N.
dc.contributor.authorUysal S.
dc.contributor.authorBernay F.
dc.contributor.authorCurses N.
dc.date.accessioned2020-06-21T09:15:21Z
dc.date.available2020-06-21T09:15:21Z
dc.date.issued2001
dc.identifier.issn0019-5456
dc.identifier.urihttps://doi.org/10.1007/BF02728849
dc.identifier.urihttps://hdl.handle.net/20.500.12712/2699
dc.descriptionPubMed: 11237229en_US
dc.description.abstractFifty-six patients with postpneumonic empyema were treated by sulbactam/ampicillin or cephalothin and netilmicin. Dose of sulbactam/ampicillin was 200mg/kg per day and of cephalothin was 200mg/kg per day, and of netilmicin was 5mg/kg per day. Sulbactam/ampicillin alone was used in 27 patients. Twenty-nine patients were treated with cephalothin plus netilmicin. Days on intravenous antibiotics, days with chest tube, decortication rate, and duration of hospitalization were significantly shorter in sulbactam/ampicillin treatment group compared to cephalothin plus netilmicin group. This study shows that sulbactam/ampicillin is a safe and effective agent in the treatment of postpneumonic empyema in childhood.en_US
dc.language.isoengen_US
dc.publisherThe Indian Journal of Pediatricsen_US
dc.relation.isversionof10.1007/BF02728849en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildhooden_US
dc.subjectEmpyemaen_US
dc.subjectSulbactam/ampicillinen_US
dc.subjectTreatmenten_US
dc.titlePostpneumonic empyema in childhooden_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume68en_US
dc.identifier.issue1en_US
dc.identifier.startpage11en_US
dc.identifier.endpage14en_US
dc.relation.journalIndian Journal of Pediatricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster